Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination

NCT00001132 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Abacavir sulfate

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)